We embrace science and innovation

Size: px

Start display at page:

Download "We embrace science and innovation"

Doris Mathews
6 years ago
Views:

1 Product Catalogue

2 We embrace science and innovation

3 TABLE of CONTENTS 8 Long Acting Injectables 12 Differentiated Products Preservative Free Ophthalmics in Multi-Dose Vials 16 Differentiated Products Oral Solids 4 Company Profile 6 Our Values 20 Generic Finished Dosage 34 Active Pharmaceutical Ingredients

4 we deliver high quality Products and Services with proven benefits to our Customers and Society company profile Pharmathen was founded in 1969 as a private pharmaceutical company and is focused on developing and marketing innovative health care products, with a strong position in Generics and Specialty products. With a long history of and manufacturing of pharmaceutical products, Pharmathen has emerged as one of the largest companies in Europe. Today, the in-house products of Pharmathen are registered in all major Global markets including the EU, North America, South Africa, LATAM, MENA, APAC & Australia and are partnered with the leading pharmaceutical companies in all of these markets. In addition, Pharmathen is able to provide a completely backward integrated service to its partners, from the synthesis of the API, to the formulation and finally to the production and supply of the finished product. p. 04 pharmathen - Product CATALOGUE pharmathen - Product CATALOGUE p. 05

our values 01 INNOVATION change that unlocks new value Our continuous progress and growth depends on the investments we make on scientific research for new medicines and technologies.

5 our values 01 INNOVATION change that unlocks new value Our continuous progress and growth depends on the investments we make on scientific research for new medicines and technologies. Innovation is part of our DNA and a process involving multiple aspects of dynamic activities 03 LEADERSHIP we walk our talk We promote a positive working environment, and apply a visionary leadership style to influence and achieve excellent results. Our leaders step out of the executive suits and do things that symbolize our shared vision 02 PERANCE 04 Passion for results Our employees are the driving force of our success. We embrace them with pride and trust and empower them to achieve operational excellence through knowledge sharing and continuous improvement QUALITY intelligent effort in everyday practice We pay attention to detail and take decisions acknowledging that our reputation depends on the empowerment of every individual to respond efficiently, perform proactively and act with care in the service of our customers 05 INTEGRITY Transparency in all we do Transparency and honesty are embedded in our DNA. Our company's code of conduct ensures that all our employees and partners make decisions that are consistent with our values, achieving the highest quality standards in our operating model p. 06 pharmathen - Product CATALOGUE pharmathen - Product CATALOGUE p. 07

6 LONG ACTING INJECTABLES We are changing the perception of conventional injectable medication, improving the effectiveness of drug therapy and enhancing patient compliance p. 08 pharmathen - Product CATALOGUE pharmathen - Product CATALOGUE p. 09

7 Product CATALOGUE Long Acting Injectables Product CATALOGUE Long Acting Injectables ARIPIPRAZOLE ARIPIPRAZOLE LAUROXIL EXENATIDE 300mg/vial 400mg/vial & 300mg/syringe 400mg/syringe 441mg/syringe 662mg/syringe 882mg/syringe 1064mg/syringe 2mg/pen Treatment of schizophrenia Treatment of schizophrenia Adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus Q2-Q NALTREXONE OCTREOTIDE ACETATE PALIPERIDONE PALMITATE 1M 380mg/vial 10mg/vial 20mg/vial 30mg/vial 25mg/syringe 50mg/syringe 75mg/syringe 100mg/syringe 150mg/syringe Treatment of alcohol dependence Treatment of acromegaly and control symptoms such as diarrhoea or flushing in patients with tumours 1-monthly injection indicated for the treatment of schizophrenia in adult patients Q New Q EXENATIDE 2mg/vial Adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus Q PALIPERIDONE PALMITATE 3M 175mg/syringe 263mg/syringe 350mg/syringe 525mg/syringe a 3-monthly injection, indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1-monthly paliperidone palmitate injectable product LANREOTIDE 60mg/syringe 90mg/syringe 120mg/syringe Long-term treatment of acromegaly; the treatment of patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) Q PASIREOTIDE 20mg/vial 40mg/vial 60mg/vial Treatment of patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option LEUPROLIDE ACETATE 7.5mg/syringe 11.25mg/syringe 15mg/syringe 22.5mg/syringe 30mg/syringe 45mg/syringe Palliative treatment of advanced prostatic cancer RISPERIDONE 12.5mg/vial 25mg/vial 37.5mg/vial 50mg/vial Acute and chronic schizophrenic psychoses treatment Q p. 10 pharmathen - Product CATALOGUE pharmathen - Product CATALOGUE p. 11

8 DIFFERENTIATED S Ophthalmics IN MULTI-DOSE VIALS Approaching the eye-care market with sophisticated cost effective and convenient multi-dose preservative free products p. 12 pharmathen - Product CATALOGUE pharmathen - Product CATALOGUE p. 13

9 Product CATALOGUE Preservative Free Ophthalmics in Multi-dose Vials Product CATALOGUE Preservative Free Ophthalmics in Multi-dose Vials BIMATOPROST 0.3mg/ml Reduction of elevated intraocular pressure in chronic open-angle glaucoma and ocular hypertension in adults DORZOLAMIDE 20mg/ml Intraocular pressure elevation treatment BIMATOPROST 0.1mg/ml Reduction of elevated intraocular pressure in chronic open-angle glaucoma and ocular hypertension in adults Q LATANOPROST 0.05mg/ml Reduction of elevated intraocular pressure New BIMATOPROST TIMOLOL 0.3mg/ml & 5mg/ml Reduction of intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues. LATANOPROST TIMOLOL 0.05mg/ml & 5mg/ml Reduction of intraocular pressure (IOP) in patients with open angle glaucoma and ocular hypertension New BRIMONIDINE Eye drops, solution 2mg/ml Reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. LIFITEGRAST Ophthalmic solution 50mg/ml Lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the treatment of the signs and symptoms of dry eye disease (DED) BRIMONIDINE TIMOLOL Eye drops, solution 2mg/ml & 5mg/ml Reduction of intraocular pressure (IOP) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers OLOPATADINE 1mg/ml Treatment of ocular signs and symptoms of seasonal allergic conjunctivitis. BRINZOLAMIDE Eye drops, suspension 10mg/ml Indicated to decrease elevated intraocular pressure in ocular hypertension and open-angle glaucoma TIMOLOL 2.5mg/ml 5mg/ml Elevated intraocular pressure decrease CHLORAMPHEN- ICOL PRESERVA- TIVE 5mg/ml Topical antibacterial in the treatment of superficial ocular infections TRAVOPROST 40mcg/ml Elevated intraocular pressure decrease DORZOLAMIDE / TIMOLOL DEXAMETHASONE 20mg/ml & 5mg/ml 1mg/ml Intraocular pressure elevation treatment Treatment of non-infectious inflammatory conditions TRAVOPROST TRAVOPROST & TIMOLOL 30mcg/ml 40mcg/ml & 5mg/ml Elevated intraocular pressure decrease Elevated intraocular pressure decrease p. 14 pharmathen - Product CATALOGUE pharmathen - Product CATALOGUE p. 15

10 DIFFERENTIATED S ORAL SOLIDS Differentiated Oral Solid products can be developed into sustainable brands since they aim to solve unmet patient needs p. 16 pharmathen - Product CATALOGUE pharmathen - Product CATALOGUE p. 17

Product CATALOGUE Differentiated Oral Solids DIMENHYDRINATE SUBLINGUAL Sublingual tablets 50mg Prevention and treatment of nausea, vomiting, and/or vertigo associated with motion sickness OSPEMIFENE

11 Product CATALOGUE Differentiated Oral Solids DIMENHYDRINATE SUBLINGUAL Sublingual tablets 50mg Prevention and treatment of nausea, vomiting, and/or vertigo associated with motion sickness OSPEMIFENE Soft Gelatin Capsules TBD Oestrogen agonist/antagonist indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause RISEDRONATE SUPRA Coated IR tablets TBD Treatment and prevention of osteoporosis in postmenopausal women, increase of bone mass in men with osteoporosis, treatment and prevention of glucocorticoid-induced osteoporosis, treatment of Paget's disease We Embrace Science and Innovation SEVELAMER CARBONATE CHEWABLE Fast disintegrating chewable tablets 800mg Control of serum phosphorous in patients with chronic kidney disease SODIUM OXYBATE Modified Release TBD Central nervous system depressant indicated for the treatment of: Cataplexy in narcolepsy and Excessive daytime sleepiness (EDS) in narcolepsy TADALAFIL FAST ACTING Fast acting coated tablets 2.5mg, 5mg 10mg, 20mg Treatment of Erectile Dysfunction p. 18 pharmathen - Product CATALOGUE pharmathen - Product CATALOGUE p. 19

12 GENERIC FINISHED DOSAGE Research, innovation and IP protection at the disposal of our highly competitive business model p. 20 pharmathen - Product CATALOGUE pharmathen - Product CATALOGUE p. 21

13 Product CATALOGUE Product CATALOGUE ALENDRONATE & CHOLECALCIF- EROL tablets 70mg/2800IU 70mg/5600IU Postmenopausal osteoporosis BRINZOLAMIDE BRIMONIDINE eye drops, suspension 10mg/ml 2mg/ml Reduction of elevated intraocular pressure in open-angle glaucoma APREPITANT hard capsules 40mg, 80mg 125mg, 165mg Prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy in adults New BRINZOLAMIDE TIMOLOL eye drop suspension 10mg/ml & 5mg/ml Treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma ARIPIPRAZOLE orodispersible tablets 10mg, 15mg 30mg Schizophrenia, manic episode treatment BUPRENORPHINE + NALOXONE sublingual film 2mg/0.5mg 4mg/1mg 8mg/2mg 12mg/3mg Substitution treatment for opioid drug dependence Q ARIPIPRAZOLE tablets 5mg, 10mg 15mg, 30mg Schizophrenia, manic episode treatment CASPOFUNGIN powder for concentrate for solution for infusion 50mg, 70mg Invasive candidiasis, invasive aspergillosis treatment ATOMOXETINE hard capsules 10mg, 18mg 25mg, 40mg 60mg, 80mg 100mg Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) CEFUROXIME AXETIL 125mg, 250mg 500mg Mild to severe infections treatment ATORVASTATIN 10mg, 20mg 40mg, 80mg Hypercholesterolaemia treatment, cardiovascular disease prevention CIPROFLOXACIN solution for infusion 100mg/50ml 200mg/100ml 400mg/200ml Infections treatment BIMATOPROST eye drops, solution 0.1mg/ml 0.3mg/ml Reduction of elevated intraocular pressure in open angle glaucoma or ocular hypertension CIPROFLOXACIN 250mg, 500mg 750mg Infections treatment BRINZOLAMIDE eye drop suspension 10mg/ml Intraocular Pressure Elevation Treatment & Open-angle Glaucoma CISATRACURIUM BESYLATE solution for injection 2mg/ml 5mg/ml Adjunct to general anaesthesia CLOPIDOGREL 75mg Prevention of Atherothrombotic & Thromboembolic Events p. 22 pharmathen - Product CATALOGUE pharmathen - Product CATALOGUE p. 23

14 Product CATALOGUE Product CATALOGUE CYCLOSPORINE DARUNAVIR DEFERASIROX Ophthalmic emulsion Tablets 0.5mg/ml 75mg, 150mg 300mg, 400mg 600mg, 800mg 90mg, 180mg 360mg Calcineurin inhibitor immunosuppressant indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs Treatment of patients with human immunodeficiency virus (HIV-1) infection Treatment of chronic iron overload due to frequent blood transfusions Q ENTECAVIR EPLERENONE ESCITALOPRAM ESOMEPRAZOLE powder for solution for injection/infusion 0.5mg, 1mg 25mg, 50mg 5mg, 10mg 15mg, 20mg 40mg Indicated for the treatment of chronic hepatitis B virus (HBV) infection Beta-blockers therapy Major depressive episodes, panic disorder, social anxiety disorder, generalized anxiety disorder & obsessive-compulsive disorder treatment Gastric antisecretory treatment for adults and children DIMENHYDRINATE DIMETHYL FUMARATE DORZOLAMIDE Sublingual tablets Gastro-resistant hard capsules 50mg 120mg, 240mg 20mg/ml Prevention and treatment of motion sickness. Symptomatic treatment of short duration of nausea and vomiting not accompanied with fever. Treatment of adult patients with relapsing-remitting multiple sclerosis Intraocular pressure elevation treatment FEBUXOSTAT FINASTERIDE FINGOLIMOD hard capsules 80mg, 120mg 5mg 0.5mg Treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred Benign prostatic hyperplasia (BPH) treatment and control Indicated as single disease-modifying therapy in highly active relapsing-remitting multiple sclerosis New New DORZOLAMIDE / TIMOLOL 20mg/ml & 5mg/ml Intraocular pressure elevation treatment FLUCONAZOLE solution for infusion 50mg/25ml 100mg/50ml 200mg/100ml 400mg/200ml Anti-infective therapy DULOXETINE hard gastro-resistant capsules 30mg, 60mg Treatment of depression and generalized anxiety disorder. Treatment of diabetic peripheral neuropathic pain FLUVASTATIN XL prolonged release tablets 80mg Dyslipidaemia adjunct to diet & Secondary prevention in coronary heart disease p. 24 pharmathen - Product CATALOGUE pharmathen - Product CATALOGUE p. 25

15 Product CATALOGUE Product CATALOGUE GALANTAMINE 4mg, 8mg 12mg Dementia of the Alzheimer type symptomatic treatment LEVETIRACETAM concentrate for solution for infusion 100mg/ml Epilepsy treatment GALANTAMINE SR prolonged-release hard capsules 8mg, 16mg 24mg Dementia of the Alzheimer type symptomatic treatment LEVETIRACETAM oral solution 100mg/ml Epilepsy treatment IBANDRONATE concentrate for solution for infusion 1mg/1ml 2mg/2ml 6mg/6ml Prevention of Skeletal Events & Treatment of Hypercalcaemia LEVETIRACETAM 250mg, 500mg 750mg, 1000mg Epilepsy treatment IBANDRONATE ONCE A MONTH 150mg Postmenopausal osteoporosis treatment LEVOFLOXACIN solution for infusion 5mg/ml Infections treatment IBANDRONATE 50mg Prevention of Skeletal Events in Patients with Cancer LEVOFLOXACIN 250mg, 500mg Infections treatment IVABRADINE 5mg, 7.5mg Treatment of coronary artery disease LINEZOLID 600mg Nosocomial & community acquired pneumonia treatment IVABRADINE ISOTRETINOIN LEFLUNOMIDE soft gel. capsules 2.5mg 5mg, 10mg 20mg 10mg, 20mg 100mg Treatment of coronary artery disease Severe forms of acne treatment Active rheumatoid arthritis treatment psoriatic arthritis treatment Q LIFITEGRAST LOSARTAN LOSARTAN+HCTZ ophthalmic solution 50 mg/ml 12.5mg, 25mg 50mg, 100mg 50/12.5mg 100/25mg Lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the treatment of the signs and symptoms of dry eye disease (DED) Essential hypertension treatment Essential hypertension treatment p. 26 pharmathen - Product CATALOGUE pharmathen - Product CATALOGUE p.27

16 Product CATALOGUE Product CATALOGUE MEMANTINE f.c.tablets 10mg, 20mg Moderate to Severe Alzheimer s Disease Treatment OLANZAPINE powder for solution for injection 10mg/vial Treatment of Schizophrenia or Manic Episode bipolar disorder recurrence prevention (manic episode patients responding to therapy) MEROPENEM MONTELUKAST powder for solution for injection or infusion 500mg, 1g 10mg Infections treatment Asthma treatment ONDANSETRON solution for Injection 4mg/2ml 8mg/4ml Management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, and for the prevention and treatment of post-operative nausea and vomiting MONTELUKAST chewable tablets 4mg, 5mg Asthma treatment ONDANSETRON 4mg, 8mg Management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, and for the prevention and treatment of post-operative nausea and vomiting MOXIFLOXACIN MOXIFLOXACIN MOXIFLOXACIN solution for infusion 5mg/ml 400mg 400mg/250ml Bacterial infections treatment Bacterial infections treatment Bacterial infections treatment PALIPERIDONE PARICALCITOL prolonged-release tablets solution for injection 1.5mg, 3mg 6mg, 9mg 12mg 5mcg/ml 10mcg/2ml 2mcg/ml 4mcg/2ml Schizophrenia treatment Prevention and treatment of secondary hyperparathyroidism in patients with chronic renal failure undergoing haemodialysis New OLANZAPINE OLANZAPINE orodispersible tablets 5mg, 10mg 15mg, 20mg 2.5mg, 5mg 7.5mg, 10mg 15mg, 20mg Treatment of Schizophrenia or Manic Episode bipolar disorder recurrence prevention (manic episode patients responding to therapy) Treatment of Schizophrenia or Manic Episode bipolar disorder recurrence prevention (manic episode patients responding to therapy) PRASUGREL PREGABALIN capsules 5mg, 10mg 25mg, 50mg 75mg, 100mg 150mg, 200mg 225mg, 300mg Prevention of atherothrombotic events in adult patients with acute coronary syndrome Neuropathic pain, epilepsy and generalised anxiety disorder treatment New p. 28 pharmathen - Product CATALOGUE pharmathen - Product CATALOGUE p. 29

17 Product CATALOGUE Product CATALOGUE QUETIAPINE SR QUETIAPINE SR RALOXIFENE REPAGLINIDE prolonged-release tablets prolonged-release tablets tablets 50mg, 150mg 200mg, 300mg 400mg 600mg 60mg 0.5mg, 1mg 2mg Schizophrenia and bipolar disorder treatment Schizophrenia and bipolar disorder treatment Postmenopausal osteoporosis treatment and prevention Type 2 diabetes adjunct to diet Q RIZATRIPTAN RIZATRIPTAN ROPINIROLE ROPINIROLE SR ROPIVACAINE orodispersible tablet tablets prolonged-release tablets solution for infusion in bags 100ml, 200ml 5mg, 10mg 5mg, 10mg 0.25mg, 0.5mg 1mg, 2mg, 5mg 2mg, 3mg 4mg, 8mg 2mg/ml Headache phase of migraine attacks acute treatment Headache phase of migraine attacks acute treatment Parkinson's disease treatment Parkinson's disease treatment Surgical anaesthesia & acute pain management RISEDRONATE RISPERIDONE 5mg, 30mg 35mg 0.5mg, 1mg 2mg, 3mg 4mg, 6mg Postmenopausal Osteoporosis Treatment & Paget's disease (30mg). Treatment of osteoporosis in men at high risk of fractures (35mg) Acute and chronic schizophrenic psychoses treatment ROPIVACAINE SEVELAMER CARBONATE solution for injection In vials 10ml, 20ml 2mg/ml 5.0mg/ml 7.5mg/ml 10mg/ml 800mg Surgical anaesthesia & acute pain management Hyperphosphataemia control RIVASTIGMINE oral solution 2mg/ml Dementia of the Alzheimer type symptomatic treatment. Treatment of dementia in patients with idiopathic Parkinson's disease. SEVELAMER HCL SILDENAFIL 800mg 25mg, 50m 100mg Hyperphosphataemia control Erectile dysfunction in adult males treatment RIVASTIGMINE hard capsules 1.5mg, 3mg 4.5mg, 6mg Dementia of the Alzheimer type symptomatic treatment. Treatment of dementia in patients with idiopathic Parkinson's disease. TACROLIMUS CR prolonged-release hard capsules 0.5mg, 1mg 3mg, 5mg Prophylaxis of transplant rejection in adult kidney or liver allograft recipients Q p. 30 pharmathen - Product CATALOGUE pharmathen - Product CATALOGUE p. 31

18 Product CATALOGUE Product CATALOGUE TAPENTADOL CR prolonged-release tablets 50mg, 100mg 150mg, 200mg 250mg Treatment of severe chronic pain in adults which can be adequately managed only with opioid analgesics Q VALACICLOVIR 500mg Herpes zoster, herpes simplex therapy & CMV infection prophylaxis TOLTERODINE 1mg, 2mg Urge incontinence symptomatic treatment VALGANCICLOVIR 450mg Cytomegalovirus (CMV) retinitis in patients with AIDS treatment TOLTERODINE SR prolonged-release hard capsules 2mg, 4mg Urge incontinence symptomatic treatment VENLAFAXINE IR tablets 37.5mg, 50mg 75mg Treatment & recurrence prevention for major depressive episodes generalized anxiety disorder, social anxiety disorder & panic disorder treatment TOPIRAMATE 25mg, 50mg 100mg, 200mg Epilepsy treatment VENLAFAXINE Prolonged-release hard capsules 37.5mg, 75mg 150mg Treatment & recurrence prevention for major depressive episodes generalized anxiety disorder, social anxiety disorder & panic disorder treatment TRANDOLAPRIL capsules 0.5mg, 1mg 2mg, 4mg Mild or moderate hypertension VILDAGLIPTIN tablets 50mg Treatment of type 2 diabetes mellitus New TRAVOPROST eye drops solution 40mcg/ml Elevated intraocular pressure decrease VILDAGLIPTIN METIN 50/500mg 50/850mg 50/1000mg Treatment of type 2 diabetes mellitus Q TRAVOPROST eye drops solution 30mcg/ml Elevated intraocular pressure decrease VORICONAZOLE 50mg, 200mg Broad spectrum antifungal TRAVOPROST & TIMOLOL eye drops solution 40mcg/ml & 5mg/ml Elevated intraocular pressure decrease VORICONAZOLE powder for solution for infusion 200mg Broad spectrum antifungal p. 32 pharmathen - Product CATALOGUE pharmathen - Product CATALOGUE p. 33

19 ACTIVE INGREDIENTS We transform new knowledge to innovative synthetic processes, designed to ensure quality efficiency and sustainability p. 34 pharmathen - Product CATALOGUE pharmathen - Product CATALOGUE p. 35

20 Product CATALOGUE API Commercially Product CATALOGUE API Commercially Indication EU DMF US DMF Indication EU DMF US DMF Aprepitant Prevention of acute and delayed chemotherapy - induced nausea and vomiting (CINV) and for prevention of postoperative nausea and vomiting Submitted preparation Linezolid Form I Linezolid Form II Infection treatment Infection treatment Ready for submission Aripiprazole Brinzolamide Dimethyl Fumarate Treatment of Schizophrenia Ocular hypertension / Open-angle Glaucoma Immunomodulator DMF No.# Paliperidone Pregabalin Ropinirole HCl Ropivacaine Treatment of Schizophrenia Management of neuropathic pain and treatment of epilepsy Parkinson s disease Anaesthesia Submitted DMF No.#31062 Duloxetine HCl Depressive disorder Tolterodine Tartrate Treatment of Overactive bladder DMF No.#24345 Febuxostat Chronic management of Hyperuricemia Submitted Valganciclovir HCl Treatment of Cytomegalovirus (CMV) Retinitis Submitted DMF No.# Fluvastatin Na Cholesterol Lowering Venlafaxine HCl Depressive disorder Ibandronate Na H2O Treatment & Prevention of Postmenopausal Osteoporosis Vildagliptin Voriconazole Antidiabetic Treatment of Invasive Aspergillosis fungal infection DMF No.# p. 36 pharmathen - Product CATALOGUE pharmathen - Product CATALOGUE p. 37

21 Product CATALOGUE API R&D Product CATALOGUE API R&D Indication samples 6 MONTHS ACCELERATED STABILITY DATA Indication samples 6 MONTHS ACCELERATED STABILITY DATA Aripiprazole Lauroxil Treatment of Schizophrenia Paliperidone Palmitate Treatment of Schizophrenia Completed Clopidogrel Acute Coronary Syndrome Completed Raltegravir Antiviral Completed Dronedarone Atrial fibrillation risk reduction Completed Rivaroxaban Anticoagulant Completed Fingolimod HCl Treatment of multiple sclerosis Completed Solifenacin Succinate Treatment of overactive bladder Completed Ivabradine Angina Completed Tadalafil Erectile Dysfunction & Benign Prostatic Hyperplasia Completed Lacosamide Anticonvulsant, Analgesic Completed ODV succinate Antidepressant, non-hormonal treatment for menopause Completed Tapentadol Centrally acting opioid analgesic p. 38 pharmathen - Product CATALOGUE pharmathen - Product CATALOGUE p. 39

Our Values. Quality Intelligent efforts in everyday practice. Innovation Change that unlocks new value. Performance Passion for results

Our Values. Quality Intelligent efforts in everyday practice. Innovation Change that unlocks new value. Performance Passion for results Product Guide Our Values 1 Innovation Change that unlocks new value Our continuous progress and growth depends on the investments we make on scientific research for new medicines and technologies. Innovation